| Product Name | InVivoSIM anti-human NGF (Tanezumab Biosimilar) |
|---|---|
| Target | Human NGF |
| Isotype | Human IgG2, κ |
| Reactivity | Human |
| Endotoxin | ≤0.5EU/mg (≤0.0005EU/μg) Determined by LAL assay |
| Purification | Protein A |
| Purity | ≥95% Determined by SDS-PAGE |
| Application | in vivo NGF neutralization ELISA |
| Formulation | PBS, pH 7.0 Contains no stabilizers or preservatives |
| Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
| Clone Number | Tanezumab |
|---|
| Molecular Weight(MW) | 150 kDa |
|---|
